Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Victoza
Research
GLP-1 drug hydrogels could reduce shots to 3 times a year
A single injection of the gel secreted therapeutic doses of semaglutide and liraglutide for 42 days in rats.
Helen Floersh
Nov 28, 2023 11:30am
Could a three-part diabetes drug ease Alzheimer’s?
Dec 31, 2017 7:00pm
Targeting microRNA to improve GLP-1 diabetes drugs
Nov 9, 2017 2:06pm
Novo’s semaglutide cuts CV events in diabetes, with 2016 filing on the horizon
Sep 16, 2016 5:39am
Bristol-Myers Squibb pulls out of Biocon oral insulin pact
May 17, 2016 8:12am
